EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Population Pharmacokinetics of Vancomycin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy: Influence of Adsorptive Membranes

Chidtawan Hirunsomboon iD, Adisorn Pathumarak, Wichit Nosoongnoen iD, Vichapat Tharanon, Sayamon Sukkha iD

Clinical and Translational Science · 2026

DOI: 10.1111/cts.70511 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Science, 2026. Verfasst von Chidtawan Hirunsomboon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Vancomycin, Anti-Bacterial Agents, Continuous Renal Replacement Therapy, Membranes, Artificial. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vancomycin is commonly used to treat Staphylococcus aureus infections. In critically ill patients receiving continuous renal replacement therapy (CRRT), adsorptive membranes like oXiris may alter drug pharmacokinetics. This retrospective study developed a population pharmacokinetics (PopPK) model using MonolixSuite software, incorporating adsorptive membrane use as a covariate. The final one‐compartment model estimated that the population volume of distribution of vancomycin was 94.97 L (RSE 10.5%) and population clearance was 2.82 L/h (RSE 19.0%). Adsorptive membrane use was a significant covariate, slightly increasing vancomycin clearance, while aging was associated with reduced clearance. Monte Carlo simulations indicated that a regimen of 2 g loading dose followed by 1 g every 24 h achieved an AUC 0–24 /MIC ≥ 400 mg h/L in more than 90% of patients. Individualized vancomycin dosing in this population should consider membrane type, along with patient‐specific factors such as age, to optimize therapeutic outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VancomycinAnti-Bacterial AgentsContinuous Renal Replacement TherapyMembranes, ArtificialStaphylococcal InfectionsHumansCritical IllnessRetrospective StudiesFemaleMiddle AgedMaleAgedModels, BiologicalMonte Carlo MethodMicrobial Sensitivity TestsAged, 80 and overAdultMetabolic Clearance RateArea Under Curve

Stichwörter der Autor:innen

adsorptive membranecontinuous renal replacement therapypopulation pharmacokineticsvancomycin

Substanzen

VancomycinAnti-Bacterial AgentsMembranes, Artificial

Autor:innen und Institutionen

  • Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.
  • College of Pharmacotherapy of Thailand, Nonthaburi, Thailand.
  • Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
  • Department of Clinical Pharmacy, Ramathibodi Hospital, Bangkok, Thailand.

ORCID-Profile: Chidtawan Hirunsomboon, Wichit Nosoongnoen, Sayamon Sukkha

Zitieren

APA

Hirunsomboon, C., Pathumarak, A., Nosoongnoen, W., Tharanon, V., & Sukkha, S. (2026). Population Pharmacokinetics of Vancomycin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy: Influence of Adsorptive Membranes. Clinical and Translational Science. https://doi.org/10.1111/cts.70511

Vancouver

Hirunsomboon C, Pathumarak A, Nosoongnoen W, Tharanon V, Sukkha S. Population Pharmacokinetics of Vancomycin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy: Influence of Adsorptive Membranes. Clinical and Translational Science. 2026. doi:10.1111/cts.70511

BibTeX
@article{Hirunsomboon2026,
  author = {Hirunsomboon, Chidtawan and Pathumarak, Adisorn and Nosoongnoen, Wichit and Tharanon, Vichapat and Sukkha, Sayamon},
  title = {Population Pharmacokinetics of Vancomycin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy: Influence of Adsorptive Membranes},
  journal = {Clinical and Translational Science},
  year = {2026},
  doi = {10.1111/cts.70511}
}
Kostenlos starten →